- Home
- ACIU vs SKYH Comparison
ACIU vs SKYH Comparison
Compare ACIU & SKYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- SKYH
- Stock Information
- Founded
- ACIU 2003
- SKYH 2017
- Country
- ACIU Switzerland
- SKYH United States
- Employees
- ACIU N/A
- SKYH N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- SKYH Military/Government/Technical
- Sector
- ACIU Health Care
- SKYH Industrials
- Exchange
- ACIU Nasdaq
- SKYH Nasdaq
- Market Cap
- ACIU 305.7M
- SKYH 335.4M
- IPO Year
- ACIU 2016
- SKYH N/A
- Fundamental
- Price
- ACIU $3.23
- SKYH $11.29
- Analyst Decision
- ACIU Strong Buy
- SKYH Strong Buy
- Analyst Count
- ACIU 2
- SKYH 2
- Target Price
- ACIU $12.00
- SKYH $15.50
- AVG Volume (30 Days)
- ACIU 131.4K
- SKYH 69.1K
- Earning Date
- ACIU 11-05-2024
- SKYH 11-12-2024
- Dividend Yield
- ACIU N/A
- SKYH N/A
- EPS Growth
- ACIU N/A
- SKYH N/A
- EPS
- ACIU N/A
- SKYH N/A
- Revenue
- ACIU $48,505,404.00
- SKYH $12,357,000.00
- Revenue This Year
- ACIU N/A
- SKYH $88.91
- Revenue Next Year
- ACIU $938.44
- SKYH $109.92
- P/E Ratio
- ACIU N/A
- SKYH N/A
- Revenue Growth
- ACIU 4097200.00
- SKYH 107.82
- 52 Week Low
- ACIU $2.25
- SKYH $7.75
- 52 Week High
- ACIU $5.14
- SKYH $13.60
- Technical
- Relative Strength Index (RSI)
- ACIU 54.88
- SKYH 48.13
- Support Level
- ACIU $3.11
- SKYH $11.11
- Resistance Level
- ACIU $3.41
- SKYH $12.94
- Average True Range (ATR)
- ACIU 0.23
- SKYH 0.53
- MACD
- ACIU 0.03
- SKYH -0.02
- Stochastic Oscillator
- ACIU 46.72
- SKYH 26.66
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About SKYH Sky Harbour Group Corporation
Sky Harbour Group Corp is an aviation infrastructure company building a nationwide network of Home-based solutions for business aircraft. The company develops, leases, and manages business aviation hangars across the United States based on its proprietary targeting and acquisition model, targeting airfields with hangar supply and demand imbalances in the markets. Its hangar campuses feature exclusive private hangars and a full suite of dedicated services specifically designed for home-based aircraft.